经尿道前列腺钬激光剜除术和经尿道前列腺电切术对良性前列腺增生患者尿流率残余尿量和性功能的影响

doi:10.3969/j.issn.1006-6233.2023.06.026

Abstract
Figure/Table
References
Related Citation (4)

Download: PDF (1223 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the influence of HoLEP and TURP on urinary flow rate, residual urine volume and sexual function in patients with BPH. Methods: This study retrospectively reviewed 256 patients with BPH admitted to the hospital between May 2020 and April 2022. Patients treated with HoLEP and TURP were defined as HoLEP group (n=126) and TURP group (n=130). Comparison was made between groups in terms of urinary flow rate, residual urine volume, and sexual function. Results: After operation, the maximum flow rate and international erectile function index (IIEF-5) of both groups were higher than before operation, while residual urine volume, international prostate symptom score (IPSS), and quality of life score (QOL) were lower than before operation (P<0.05). The difference in maximum flow rate, residual urine volume, IIEF-5 score, IPSS score, and QOL score before and after operation in the HoLEP group was higher than that in the TURP group (P<0.05). The incidence of retrograde ejaculation after operation in the HoLEP group was lower than that in the TURP group (P<0.05). Conclusion: Compared with TURP, HoLEP can improve urine flow rate and reduce residual urine volume, reduce erectile dysfunction and retrograde ejaculation, and improve sexual function in patients with BPH. It is minimally invasive, with high security.

Key words： Benign prostatic hyperplasia Holmium laser enucleation of the prostate Transurethral resection of the prostate Urinary flow rate Sexual function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2023.06.026 OR http://www.hbyxzzs.cn/EN/Y2023/V29/I6/1015

[1] 何跃,杨璐,魏强.良性前列腺增生的可逆转危险因素[J].四川医学,2022,43(1):99-103.
[2] 梁其炎.影响前列腺增生患者经PKRP治疗疗效的多因素预测研究[J].包头医学院学报,2022,38(5):10-12.
[3] Castellani D,Pirola GM,Rubilotta E,et al.GreenLight Laser^TM Photovaporization versus transurethral resection of the prostate:a systematic review and meta-analysis[J].Res Rep Urol,2021,20(13):263-271.
[4] Kaplan SA.Benign prostatic hyperplasia[J].Urol,2022,208(1):186-188.
[5] Syed JS,Honig S.Sexual metrics in transgender women:transitioning from international index of erectile function to female sexual function index[J].Sex Med Rev,2021,9(2):236-243.
[6] Kim SJ,Chang H,Youn I,et al.Association between prostatic 18F-FDG uptake and lower urinary tract symptoms assessed by international prostate symptom score[J].Diagn Interv Radiol,2022,28(2):179-184.
[7] Knight GM,Talwar A,Salem R,et al.Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia[J].Cardiovasc Intervent Radiol,2021,44(2):183-193.
[8] Ionson A,Monfared SHB,Ursiny M,et al.Economic evaluation of 1470nm diode laser enucleation vs bipolar transurethral resection of the prostate[J].Endourol,2021,35(8):1204-1210.
[9] Worthington J,Lane JA,Taylor H,et al.Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction:the UNBLOCS RCT[J].Health Technol Assess,2020,24(41):1-96.
[10] Hashim H,Worthington J,Abrams P,et al.Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS):a randomised controlled trial[J].Lancet,2020,396(10243):50-61.
[11] Fiekabo O,John E.TURP syndrome and relevant consideration during anaesthesia for monopolar transurethral resection of prostate[J].Clin Med Res,2022,10(1):126-129.